Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Original Article

    Preliminary Screening of Crude Extracts of Fagaropsis Angolensis for Anticancer Activity

    wadmin2By wadmin2April 9, 2018Updated:August 12, 2021No Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Antony Letoyah Yiaile1,2*, James Mucunu Mbaria2, Isaac Mpapuluu Ole-Mapenay2, Mitchel Otieno Okumu2, Abdi Hussein Hadun2, Jared Misonge Onyancha3
    1Department of Pharmacy, University Health Services, Maasai Mara University, P.O. Box 861-20500, Narok, KENYA.
    2Department of Public Health, Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Nairobi, P.O. Box 29053-00625, Nairobi, KENYA.
    3Department of Pharmacy, School of Medicine and Health Sciences, Kenya Methodist University, P.O BOX 267-60200 Meru, KENYA.

    Pharmacognosy Communications,2018,8,2,75-80.
    DOI: 10.5530/pc.2018.2.15
    Published: January 2018
    Type: Original Article

    ABSTRACT

    Background: The use of conventional cancer medication is limited by cytotoxicity on normal cells, intolerability of the drugs used and emergence of aggressive tumors which do not respond to treatment. Herbal alternatives are now being touted to be of promising efficacy. Fagaropsis angolensis (FA) has wide ranging ethno medicinal uses in Kenya. However, the anticancer potential of this plant is yet to be fully explored. The present study aims to determine the antiproliferative activity of crude extracts of Fagaropsis angolensis (FA) against African monkey kidney (Vero, E6), throat cancer (Hep2) and colon cancer (CT 26-CL 25) cell lines. Methods: Water and methanol extracts of FA were qualitatively screened to determine their phytochemical composition. In vitro growth inhibition capacity of these extracts on African monkey kidney (Vero, E6), throat cancer (HeP2) and colon cancer (CT-26-CL-25) cell lines was then assessed using the 3-(4, 5-dimethylthiazol- 2-yl)-2, 5-diphenyltetrazolium assay and expressed as 50% inhibitory concentration (IC50). Doxorubicin (standard anticancer agent) was used for comparison. Results: On Vero cell lines, statistical differences (p<0.05) were noted in the IC50 values of methanol whole root and methanol root stem extracts of FA (5.80+/-0.80μg/ml) against 1.10+/-0.70μg/ml) as well as between Doxorubicin and methanol root stem extracts of FA (6.5+/-3.25 μg/ml against 1.10+/-0.70μg/ml). On colon cancer cell lines, statistical differences (p<0.05) were noted between the IC50 values of Doxorubicin and the methanol root stem extract of FA (19.00+/-9.00ug/ml against 8.33+/-1.42μg/ml) as well as between Doxorubicin and methanol whole root extract of FA (19.00+/-9.00μg/ml against 5.25+/-0.35μg/ml). The effects of the extracts of FA on throat cancer cell lines were unremarkable. Conclusions: These findings suggest that the choice of solvent may have some effect on the IC50 values of the extracts on cancer cell lines. It may also be suggested that the methanol root stem and whole root extracts of FA may be sources of important lead molecules that may be useful in the treatment of colon cancer. Conclusion: These findings suggest that the methanol root stem and whole root extracts of FA may be sources of important lead molecules in cancer therapy.

    Key words: Fagaropsis angolensis, Kenya, Cancer, Doxorubicin.

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up